All Stories

  1. Choroidal Macrovessel Diagnosed on Multimodal Imaging, including Swept-Source Optical Coherence Tomography Angiography
  2. Chronic Endophthalmitis Caused by Pseudomonas stutzeri
  3. Apolipoprotein AI-Derived Vitreous Amyloidosis: An Elusive Diagnosis
  4. Role of peripheral pan-retinal photocoagulation in diabetic macular edema treated with intravitreal ziv-aflibercept
  5. Clinical Characteristics and Treatment of 308 Panuveitis Patients over 10 Years: Results from the KKESH Uveitis Survey Study Group
  6. Retinal detachment in albinism
  7. Phacoemulsification Outcomes with Different Illumination Techniques
  8. Peripheral Retinal Neovascularization with Vitreous Hemorrhage in HIV Retinopathy
  9. Ocular Tuberculosis
  10. Noninfectious uveitis: strategies to optimize treatment compliance and adherence
  11. Spontaneous release of epiretinal membrane in a young weight-lifting athlete by presumed central rupture and centrifugal pull
  12. Paraproteinemic Maculopathy
  13. OUTCOMES OF TREATMENT OF PEDIATRIC CHOROIDAL NEOVASCULARIZATION WITH INTRAVITREAL ANTIANGIOGENIC AGENTS
  14. INTRAOCULAR PRESSURE ELEVATION AFTER UNCOMPLICATED PARS PLANA VITRECTOMY
  15. FLUORESCEIN ANGIOGRAPHY VERSUS OPTICAL COHERENCE TOMOGRAPHY-GUIDED PLANNING FOR MACULAR LASER PHOTOCOAGULATION IN DIABETIC MACULAR EDEMA
  16. Massive Bilateral Serous Retinal Detachment in a Case of Hypertensive Chorioretinopathy
  17. Retinal imaging in uveitis
  18. Disseminated Histoplasmic Multifocal Choroiditis in AIDS
  19. High-Power Handheld Blue Laser-Induced Maculopathy
  20. Valsalva Retinopathy Associated with Sexual Activity
  21. Perfluorocarbon Liquid–Silicone Oil Interface After Vitreoretinal Surgery: Mirror Image of the Retina
  22. Clinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part I
  23. Clinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture – Part II
  24. Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2)
  25. RESIDUAL INTERNAL LIMITING MEMBRANE AFTER EPIRETINAL MEMBRANE PEELING
  26. Intravitreal Tumor Necrosis Factor-Alpha Inhibitors for Neovascular Age-Related Macular Degeneration Suboptimally Responsive to Antivascular Endothelial Growth Factor Agents: A Pilot Study from the Pan American Collaborative Retina Study Group
  27. INTRAVITREAL BEVACIZUMAB PLUS GRID LASER PHOTOCOAGULATION OR INTRAVITREAL BEVACIZUMAB OR GRID LASER PHOTOCOAGULATION FOR DIFFUSE DIABETIC MACULAR EDEMA
  28. Retinal and Choroidal Manifestations of Selected Systemic Diseases
  29. Rhegmatogenous Retinal Detachment and Bilateral Optic Disc Coloboma in Organoid Nevus Syndrome
  30. Diabetic macular edema: Current management 2013
  31. Clinical Pattern of Toxoplasmic Retinochoroiditis in a Spanish Referral Center
  32. Update on the Principles and Novel Local and Systemic Therapies for the Treatment of Non-Infectious Uveitis
  33. Smoking and Age-Related Macular Degeneration: Review and Update
  34. Chapter-14 Vitrectomy for Retinal Detachment with and without Proliferative Vitreoretinipathy
  35. Diffuse Unilateral Subacute Neuroretinitis
  36. Reply
  37. Evolution of Early Changes at the Vitreoretinal Interface After Cataract Surgery Determined by Optical Coherence Tomography and Ultrasonography
  38. Ocular Toxocariasis
  39. Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients
  40. Long-term follow-up of choroidal neovascularization secondary to angioid streaks: case series and literature review
  41. Posterior Pole Manifestations of Toxocariasis
  42. Diabetic Retinopathy
  43. Endogenous Endophthalmitis
  44. Intraocular Lymphoma
  45. Retinal and Choroidal Manifestations of Toxoplasmosis
  46. Retinal and Choroidal Manifestations of Fungal Diseases
  47. Retinal and Choroidal Manifestations of Systemic Lupus Erythematosus (SLE)
  48. Diffuse Unilateral Subacute Neuroretinitis (DUSN)
  49. Retinal and Choroidal Manifestations of HIV/AIDS
  50. Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization
  51. Crystallization After Intravitreous Foscarnet Injections
  52. Ranibizumab for serous macular detachment in branch retinal vein occlusions
  53. Intravitreal infliximab for refractory pseudophakic cystoid macular edema: results of the Pan-American Collaborative Retina Study Group
  54. Prophylaxis of Pseudophakic Cystoid Macular Edema with Intraoperative Pegaptanib
  55. Rhegmatogenous retinal detachment after LASIK for myopia of up to –10 diopters: 10 years of follow-up
  56. Imaging in the Diagnosis and Management of Diffuse Unilateral Subacute Neuroretinitis
  57. Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy
  58. Retinal Detachment after Bevacizumab
  59. Oral Propranolol for Exudative Retinal Detachment in Diffuse Choroidal Hemangioma
  60. Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema
  61. ENDOPHTHALMITIS AFTER PARS PLANA VITRECTOMY
  62. Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up
  63. ¿Quién debe aplicar las inyecciones intravítreas?
  64. INTRAVITREAL TUMOR NECROSIS FACTOR INHIBITORS IN THE TREATMENT OF REFRACTORY DIABETIC MACULAR EDEMA
  65. INTRAVITREAL BEVACIZUMAB FOR INFLAMMATORY CHOROIDAL NEOVASCULARIZATION
  66. Who should give intravitreal injections?
  67. Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture
  68. Ranibizumab for retinal arterial macroaneurysms
  69. Primary intravitreal ranibizumab for adult-onset foveomacular vitelliform dystrophy
  70. Intravitreal Ranibizumab in the Treatment of Cystoid Macular Edema Associated with Retinitis Pigmentosa
  71. Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration at Twenty-four Months: The Pan-American Collaborative Retina Study
  72. Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy
  73. Microplasmin for Vitreomacular Traction
  74. Evaluating Exaggerated, Prolonged, or Delayed Postoperative Intraocular Inflammation
  75. Intravitreal Clindamycin and Dexamethasone for Zone 1 Toxoplasmic Retinochoroiditis at Twenty-four Months
  76. Intravitreal Bevacizumab (Avastin®) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-Planas Lecture
  77. COMPARISON OF TWO DOSES OF INTRAVITREAL BEVACIZUMAB AS PRIMARY TREATMENT FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
  78. Photodynamic therapy for chronic central serous chorioretinopathy
  79. Diagnostic and Therapeutic Challenges
  80. Neovascular glaucoma
  81. Ocular Toxoplasmosis in the Developing World
  82. Endogenous Endophthalmitis in the Developing World
  83. HIV/AIDS in the Developing World
  84. LIST OF CONTRIBUTORS
  85. Ocular Nematode and Trematode Infections in the Developing World
  86. Chapter-30 Retinal Complications After Refractive Surgery
  87. Tratamiento Focal Macular guiado por el mapa de grosor retiniano del HD-OCT Cirrus® versus Angiografía Fluoresceínica en las Oclusiones Venosas de la Retina
  88. Short-term Results of a Single Intravitreal Bevacizumab (Avastin) Injection versus a Single Intravitreal Triamcinolone Acetonide (Kenacort) Injection for the Management of Refractory Noninfectious Uveitic Cystoid Macular Edema
  89. COMPARISON OF TWO DOSES OF INTRAVITREAL BEVACIZUMAB AS PRIMARY TREATMENT FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSIONS
  90. Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema
  91. Intravitreal Plasmin Without Associated Vitrectomy as a Treatment for Refractory Diabetic Macular Edema
  92. Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema
  93. Long-term Visual Outcomes of Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization
  94. Correspondence
  95. Comparing outcomes in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration treated with two different doses of primary intravitreal bevacizumab: results of the pan-american collaborative retina study group ...
  96. Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up
  97. Intravitreal Bevacizumab for Diabetic Retinopathy
  98. Retinal Angiography and Optical Coherence Tomography
  99. Chapter-07 Fluorescein and Indocyanine Green Retinal Angiography
  100. PRIMARY INTRAVITREAL BEVACIZUMAB FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION
  101. Diagnostic and Therapeutic Challenges
  102. RADIAL OPTIC NEUROTOMY FOR CENTRAL RETINAL VEIN OCCLUSION
  103. Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization
  104. En Bloc Perfluorodissection for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy
  105. Reply : Intravitreal bevacizumab in postoperative pseudophakic cystoid macular edema: Does it really work?
  106. Posterior segment complications after laser-assisted in situ keratomileusis
  107. En Bloc Perfluorodissection in Vitreoretinal Surgery: A New Surgical Technique
  108. LONG-TERM EFFECT OF INTRAVITREAL TRIAMCINOLONE IN THE NONPROLIFERATIVE STAGE OF TYPE II IDIOPATHIC PARAFOVEAL TELANGIECTASIA
  109. COMPARISON OF TWO DOSES OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION
  110. The Role of Vitreo-Retinal Surgery in Children With Uveitis
  111. Optic Neuropathy and Retinal Complications after Refractive Surgery
  112. ENDOPHTHALMITIS AFTER 25-GAUGE AND 20-GAUGE PARS PLANA VITRECTOMY
  113. Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema
  114. OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS OF GROUP 2A IDIOPATHIC PARAFOVEAL TELANGIECTASIS
  115. Simultaneous bilateral ocular decompression retinopathy after trabeculectomy with mitomycin C for uveitic glaucoma
  116. Retina and Vitreous in Latin America
  117. Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)
  118. Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study
  119. Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema
  120. Bilateral macular cyst after lightning visualized with optical coherence tomography
  121. Macular hole surgery complicated by accidental massive subretinal indocyanine green, and retinal tear
  122. Ophthalmology in Venezuela
  123. Optical Coherence Tomography Characteristics of Choroidal Metastasis
  124. INDOCYANINE GREEN–MEDIATED PHOTOTHROMBOSIS WITH AND WITHOUT INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION:
  125. Full-Thickness Macular Hole after LASIK for the Correction of Myopia
  126. Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration
  127. CHARACTERISTICS OF SIXTY MYOPIC EYES WITH PRE-LASER IN SITU KERATOMILEUSIS RETINAL EXAMINATION AND POST-LASER IN SITU KERATOMILEUSIS RETINAL LESIONS
  128. Intraoperative peripheral anterior capsulotomy to prevent early postoperative capsular block syndrome
  129. CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH TOPICAL DERMAL CORTICOSTEROIDS
  130. Retinal complications after laser-assisted in situ keratomileusis (LASIK)
  131. The relationship between AIDS retinal cotton wool spots and neuropsychological impairment in HIV-positive individuals in the pre-highly active antiretroviral therapy era
  132. RPE translocation in ARMD
  133. IMMUNE RECOVERY UVEITIS IN AIDS PATIENTS WITH CYTOMEGALOVIRUS RETINITIS TREATED WITH HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN VENEZUELA
  134. Ocular manifestations of systemic lupus erythematosus
  135. Author reply
  136. Retina and Vitreous Pathology after LASIK: author reply
  137. INDOCYANINE GREEN VIDEOANGIOGRAPHY OF MULTIFOCAL CRYPTOCOCCUS NEOFORMANS CHOROIDITIS IN A PATIENT WITH ACQUIRED IMMUNODEFICIENCY SYNDROME
  138. Temporary Retrobulbar Catheter for Local Anesthesia in Vitreoretinal Surgery
  139. Vitreoretinal conditions after LASIK: Author’s reply
  140. RHEGMATOGENOUS RETINAL DETACHMENT AFTER LASER-ASSISTED IN SITU KERATOMILEUSIS (LASIK) FOR THE CORRECTION OF MYOPIA
  141. Retinal detachment in myopic eyes after laser in situ keratomileusis
  142. Reply
  143. Reply
  144. Reply
  145. Rhegmatogenous Retinal Detachment After Laserassisted in situ Keratomileusis (LASIK) for the Correction of Myopia.
  146. RHEGMATOGENOUS RETINAL DETACHMENT AFTER LASER-ASSISTED IN SITU KERATOMILEUSIS (LASIK) FOR THE CORRECTION OF MYOPIA
  147. TOPICAL ANESTHESIA IN POSTERIOR VITRECTOMY
  148. Adverse Events and Autopsy Findings after Intravitreous Cidofovir (HPMPC) Therapy in Patients with Acquired Immune Deficiency Syndrome (AIDS)
  149. Low-dose Intravitreal Cidofovir (HPMPC) Therapy of Cytomegalovirus Retinitis in Patients with Acquired Immune Deficiency Syndrome
  150. Ocular Manifestations of the Organoid Nevus Syndrome
  151. Anterior Nongranulomatous Uveitis after Intravitreal HPMPC (Cidofovir) for the Treatment of Cytomegalovirus Retinitis
  152. Intravitreal Cidofovir for the Maintenance Treatment of Cytomegalovirus Retinitis
  153. CLINICAL VERSUS FUNDUS PHOTOGRAPHIC EVALUATION OF THE STATUS OF CYTOMEGALOVIRUS RETINTTIS IN AIDS PATIENTS
  154. POLYMERASE CHAIN REACTION DETECTION OF CYTOMEGALOVIRUS AND HUMAN IMMUNODEFICIENCY VIRUS-1 IN THE RETINA OF PATIENTS WITH ACQUIRED IMMUNE DEFICIENCY SYNDROME WITH AND WITHOUT COTTON-WOOL SPOTS
  155. Baseline Characteristics, Natural History, and Risk Factors to Progression in Eyes with Stage 2 Macular Holes
  156. Intravitreal Cidofovir (HPMPC) Treatment of Cytomegalovirus Retinitis in Patients with Acquired Immune Deficiency Syndrome
  157. Results of Rhegmatogenous Retinal Detachment Repair in Cytomegalovirus Retinitis with and without Scleral Buckling
  158. Rhegmatogenous Retinal Detachments in Patients with Acquired Immunodeficiency Syndrome
  159. Angiography of Retinal Vascular Diseases
  160. How Does Optical Coherence Tomography Work? Basic Principles
  161. Artifacts and Limitations in Time-Domain Optical Coherence Tomography Images
  162. Clinical Applications of Optical Coherence Tomography in Age-Related Macular Degeneration
  163. Angiography of Macular Diseases
  164. Clinical Applications of Optical Coherence Tomography in Diabetic Retinopathy
  165. Angiography of Optic Nerve Diseases
  166. Angiography of Retinal and Choroidal Tumors
  167. Clinical Applications of Optical Coherence Tomography in Macular Diseases
  168. Angiography of Inflammatory Diseases in Immunocompetent and Immunocompromised Patients